Financial News

Recent Quotes
My Watchlist
Indicators
Motherlode Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Sanofi-Aventis S.A. (NY: SNY )

43.41 USD UNCHANGED
Last Price Updated: 5:16 PM EST, Dec 31, 2018 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Sanofi-Aventis S.A.

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
2 Growth Stocks for In-the-Know Investors
Right now, most investors are oblivious to OptimizeRX and eXp World Holdings. Here's why you should know their names. 
Tags NVS ABBV AZN
From Motley Fool
Is It Too Late to Buy Pfizer Stock?
Time to buy the drugmaker is running out. 
Tags Market News BNTX PFE
From Motley Fool
First Week of SNY February 19th Options Trading
Investors in Sanofi (SNY) saw new options become available this week, for the February 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the SNY options chain for... 
Tags Stocks
From Market News Video
What's the Upside for Novavax Stock?
Novavax's COVID-19 vaccine could receive emergency use authorizations around the globe. In that case, how much revenue should investors expect? 
Tags NVAX SNY JNJ
From Motley Fool
A Preview Of The Busy Earnings Week Ahead
Another busy week of earnings will be in its full splendor on Tuesday with Pfizer Inc. (NYSE: PFE), Alibaba Group Holding ... 
Tags PINS SNY BMY
From Benzinga
Attention Biotech Investors: Mark Your Calendar For February PDUFA Dates
Coming off a stellar year, when a record 53 new molecular entities were approved, 2021 has a lot to live up to. NMEs are a measure of ... 
Tags Small Cap TGTX GTHX
From Benzinga
Is Vaxart Stock a Buy?
A little-known biotech is trying its hand at developing a coronavirus vaccine. Can it succeed? 
Tags SNY MRNA BNTX
From Motley Fool
Breaking Down Novavax's Coronavirus Vaccine Data: 2 Analysts Takes
Novavax, Inc. (NASDAQ: NVAX) shares were roaring higher Friday after the company reported topline results from the late-stage trial of ... 
Tags H/C/ Wainwright NVAX Health Care
From Benzinga
First Week of SNY September 17th Options Trading
Investors in Sanofi (SNY) saw new options begin trading this week, for the September 17th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time... 
Tags Stocks
From Market News Video
How The Parts Add Up: PPH Targets $78
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Why the No. 1 Healthcare Stock of 2020 Is Still a Buy
Novavax has significant upside if its phase 3 data are positive. 
Tags Market News NVAX PFE
From Motley Fool
The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Biotech Offerings VCEL
From Benzinga
Sanofi teams up with BioNTech and Pfizer to help fix Europe’s vaccine shortage
Unusual collaboration will see Sanofi supply more than 125 million doses of Pfizer–BioNTech COVID shot from the summer. 
Tags BNTX AZN PFE
From MarketWatch
Sanofi To Manufacture 125 Million COVID-19 Vaccine Doses For Rival Pfizer-BioNTech
French drug makerSanofi SA(NASDAQ: SNY) willmanufacture 125 million dosesof the COVID-19 vaccine co-developed ... 
Tags GSK News Biotech
From Benzinga
European stocks struggle and Nasdaq futures are higher with investors focused on Fed and big tech earnings
European stocks are struggling to get a positive foothold on Wednesday, as investors look to the Federal Reserve meeting later, coronavirus updates and a batch of big U.S. earnings. 
Tags NL:ASML FR:SAN GSK
From MarketWatch
5 Value Stocks In The Healthcare Sector
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. ... 
Tags ONTX Market News PSTV
From Benzinga
3 Reasons to Buy Novavax Stock, and 1 Reason to Sell
Last year's stock market star is getting ready for its big moment -- or, has it already happened? 
Tags NVAX SNY JNJ
From Motley Fool
The Biggest Drug Competition in 2021 (Hint: It Isn't COVID Vaccines)
Investors should take notice of this four-way competition. 
Tags ABBV Market News PFE
From Motley Fool
Why Novavax Could Become a Latecomer Leader in the COVID Vaccine Race
This small biotech could be like the tortoise in Aesop's famous fable. 
Tags MRNA PFE NVAX
From Motley Fool
‘Manufacturers and middlemen have created a vicious cycle of price increases’: Mark Cuban pledges to sell this $225 medication for $20
Americans pay $1,397 a year on average for prescription drugs and medical costs compared to $884 for Canadians. 
Tags AMZN IT:SANF NVO
From MarketWatch
Is Novavax's Growth Story Over?
The next few weeks could be critical for the biotech's coronavirus vaccine prospects. 
Tags Market News SNY GILD
From Motley Fool
Why Lexicon Pharmaceuticals Stock Doubled and Then Some on Thursday
The FDA delivered a powerful shot of good news to the company. 
Tags SNY LXRX Market News
From Motley Fool
Is Regeneron Stock Heading to $590?
Rapid expansion beyond the Eylea franchise is causing analysts to raise their ratings on the big biotech. 
Tags REGN SNY Market News
From Motley Fool
Sanofi Spins Off an Industry-Leading Business
After divesting its active pharmaceutical ingredient segment, the slimmed-down company will have more time to focus on developing new blockbuster drugs. 
Tags Market News SNY REGN
From Motley Fool
Biond Biologics and Sanofi Enter into Global Licensing Agreement for BND-22, a Novel Immune Checkpoint Inhibitor Targeting the ILT2 Receptor
Biond to receive $125 million upfront with more than $1 billion in potential development, regulatory, and sales milestones plus royalty payments 
From PR Newswire
3 Coronavirus Stocks to Stay Miles Away From in 2021
Their coronavirus projects fell behind, faltered, or failed. 
Tags BNTX Market News MRNA
From Motley Fool
Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines
Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines 
From Business Wire News Releases
Up 1,530% in 2020, Is Vaxart Still a Buy?
The biotech stock could still have big gains ahead, and not just because of its COVID-19 vaccine candidate. 
Tags SNY JNJ VXRT
From Motley Fool
What's Next
Today I got a promotional mail reading” “What's next?” -- particularly appropriate today after yesterday's events disarray including the still buoyant stock market. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Moderna Hires Amgen Executive As Chief Commercial Officer To Bolster Vaccine Marketing
Moderna Inc (NASDAQ: MRNA), which received the fourth regulatory nod for its investigational coronavirus vaccine with the conditional ... 
Tags vaccine Biotech Health Care
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback